NOTE 15 – INCENTIVE AND NON-STATUTORY STOCK OPTION
PLAN
Common stock purchase options consisted of the following:
OPTIONS:
SCHEDULE OF COMMON STOCK PURCHASE OPTIONS
| | |
# of shares | | |
Weighted
Average
Exercise Price | | |
Weighted
Average
Remaining
Contractual
Life (in years) | | |
Aggregated
Intrinsic
Value | |
| | |
| | |
| | |
| | |
| |
| Outstanding and exercisable, June 30, 2025 | |
| 50,000 | | |
$ | 2.94 | | |
| 1.89 | | |
| - | |
| Granted | |
| - | | |
| - | | |
| - | | |
| | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| | |
| Expired / Cancelled | |
| - | | |
| - | | |
| - | | |
| | |
| Outstanding and exercisable, March 31, 2026 | |
| 50,000 | | |
$ | 2.94 | | |
| 1.15 | | |
$ | 22,500 | |
The aggregate intrinsic value at March
31, 2026 represents the difference between the Company’s closing stock price of $3.39 on March 31, 2026 and the exercise price
of the in-the-money stock options.
NETSOL
TECHNOLOGIES, INC.
Notes
to Condensed Consolidated Financial Statements
March
31, 2026
(Unaudited)
The following table summarizes information about stock options
outstanding and exercisable at March 31, 2026.
SUMMARY OF STOCK OPTIONS OUTSTANDING
| Exercise Price | |
Number
Outstanding
and
Exercisable | | |
Weighted
Average
Remaining
Contractual
Life | | |
Weighted
Average
Exercise
Price | |
| OPTIONS: | |
| | | |
| | | |
| | |
| $2.94 | |
| 50,000 | | |
| 1.15 | | |
$ | 2.94 | |
| Totals | |
| 50,000 | | |
| 1.15 | | |
$ | 2.94 | |
|